• Companies can avoid this trap by treating future growth as a foundation, not a later stage. • Decision makers need to work backwards from scale, building software architecture and commercial architecture together. • This shift alone helps teams make smarter choices within the first 90 days of a product’s launch. • The post Why HealthTech Products Fail Clinical Deployment & How To Prevent It appeared first on MedCity News . • Companies can avoid this trap by treating future growth as a foundation, not a later stage. • Decision makers need to work backwards from scale, building software architecture and commercial architecture together.

Article Summaries:

  • MedCity News reports that HealthTech firms often fail during clinical deployment because they treat future growth as an afterthought. The article argues that decision makers should reverse‑engineer from the desired scale, designing software and commercial architecture in tandem from the outset. By adopting this forward‑looking approach, teams can make more informed choices within the first 90 days of a product’s launch, reducing the risk of costly deployment failures. The piece emphasizes that integrating growth planning into early design stages is key to successful clinical rollout.
  • Summary

A MedCity News article explains why many HealthTech products fail during clinical deployment. The core issue is that companies often treat scaling as a later concern rather than a foundational element. The piece recommends that decision makers “work backwards from scale,” designing software and commercial architectures in tandem from the outset. By integrating these systems early, teams can make more informed choices during the critical first 90 days after launch, reducing the risk of deployment failures and accelerating product adoption.

Sources: